Ftse Mib
32.665,21
-2,81%
DAX
18.002,02
-1,43%
S&P 500
5.431,60
-0,04%
NASDAQ
17.688,88
0,12%
Bitcoin
66.578,34
0,58%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Black Diamond Therapeutics Inc (BDTX) Black Diamond Therapeutics Inc (BDTX) Notizie

Black Diamond Therapeutics Inc

BDTX
6,00
-0,17 (-2,76%)
15 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
06/6/202423:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202423:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:06EDGAR2Form 8-K - Current report
01/6/202416:00GLOBEBlack Diamond Therapeutics Presents Promising BDTX-1535..
29/5/202414:00GLOBEBlack Diamond Therapeutics to Participate in Jefferies..
14/5/202401:09EDGAR2Form SC 13D/A - General statement of acquisition of..
09/5/202413:30GLOBEBlack Diamond Therapeutics Reports First Quarter 2024..
09/5/202413:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202413:10EDGAR2Form 8-K - Current report
24/4/202422:05GLOBEBlack Diamond Therapeutics Announces Presentations at the..
11/4/202414:00GLOBEBlack Diamond Therapeutics Announces Changes to Board of..
08/4/202400:00GLOBEBlack Diamond Therapeutics Presents Novel Real-World..
03/4/202414:00GLOBEBlack Diamond Therapeutics to Participate in Upcoming..
12/3/202413:00GLOBEBlack Diamond Therapeutics Reports Fourth Quarter and Full..
11/3/202418:14EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
05/3/202422:30GLOBEBlack Diamond Therapeutics Announces Upcoming Presentation..
28/2/202414:00GLOBEBlack Diamond Therapeutics to Participate in the TD Cowen..
15/2/202423:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202423:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202423:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202423:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202422:04EDGAR2Form 8-K - Current report
04/1/202414:07EDGAR2Form 8-K - Current report
04/1/202414:00GLOBEBlack Diamond Therapeutics Announces Corporate Update and..
13/12/202313:08EDGAR2Form 8-K - Current report
13/12/202313:00GLOBEBlack Diamond Therapeutics Announces Topline Results from..
07/11/202314:00GLOBEBlack Diamond Therapeutics to Participate in Upcoming..
06/11/202313:45GLOBEBlack Diamond Therapeutics Reports Third Quarter 2023..
06/11/202313:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202313:10EDGAR2Form 8-K - Current report
14/10/202318:30GLOBEBlack Diamond Therapeutics Presents Dose Escalation Data..
04/10/202318:14GLOBEBlack Diamond Therapeutics to Present Preclinical and..
18/9/202323:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/9/202313:12EDGAR2Form 8-K - Current report
18/9/202313:00GLOBEBlack Diamond Therapeutics Announces CEO Transition
11/9/202314:00GLOBEBlack Diamond Therapeutics Announces First Patients Dosed in..
05/9/202314:00GLOBEBlack Diamond Therapeutics to Participate in Upcoming..
11/8/202313:30GLOBEBlack Diamond Therapeutics Reports Second Quarter 2023..
11/8/202313:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/8/202313:22EDGAR2Form 8-K - Current report
30/6/202322:03EDGAR2Form 8-K - Current report
30/6/202322:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
30/6/202302:57GLOBEBlack Diamond Therapeutics Announces Pricing of Public..
29/6/202312:02EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28/6/202322:23GLOBEBlack Diamond Therapeutics Announces Proposed Public..
27/6/202313:00GLOBEBlack Diamond Therapeutics Announces Initial Dose Escalation..
Apertura: 6,06 Min: 5,86 Max: 6,15
Chiusura: 6,17

La tua Cronologia

NASDAQ
BDTX
Black Diamond Therapeutics
BIT
F18300
Vontobel Financial Produ...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network